Financial Snapshot

INCOME STATEMENT

(Unit: KRW Billion)
Income Statement (2018 ~ 2022)
2018 2019 2020 2021 2022
Consolidated 536 702 1,165 1,568 3,001
CDMO 536 702 1,165 1,568 2,444
Biosimilar 369 766 777 847 664
(Unit: KRW Billion)

* Consolidated financial information is prepared in accordance with K-IFRS

* Samsung Bioepis Co., Ltd. is included in the consolidated financial statements of the Company as it became a wholly-owned subsidiary of the Company on April 20th, 2022

BALANCE SHEET

(Unit: KRW Billion)
BALANCE SHEET (2018 ~ 2022)
2018 2019 2020 2021 2022
Current Assets 1,577 1,356 1,751 2,823 6,458
Non-Current Assets 4,403 4,555 4,673 5,147 10,124
Total Assets 5,980 5,911 6,424 7,970 16,582
Current Liabilities 711 690 589 1,107 4,182
Non-Current Liabilities 1,114 867 1,236 1,872 3,416
Total Liabilities 1,825 1,557 1,825 2,979 7,598
Total Equities 4,155 4,354 4,599 4,991 8,984
(Unit : KRW Billion)

* Consolidated financial information is prepared in accordance with K-IFRS

* Samsung Bioepis Co., Ltd. is included in the consolidated financial statements of the Company as it became a wholly-owned subsidiary of the Company on April 20th, 2022

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION